Beijing Ditan Hospital
Beijing Ditan Hospital: China's “Emergency Vanguard” and “Comprehensive Management Benchmark” in Infectious Disease Control
Affiliated with Capital Medical University, Beijing Ditan Hospital is a Grade A tertiary infectious disease specialty hospital directly under the Beijing Municipal Health Commission. It serves as the core supporting institution for the National Clinical Research Center for Infectious Diseases and the National Administration of Traditional Chinese Medicine's Key Laboratory for Infectious Diseases, and stands as the “national main force” in treating emerging and sudden infectious diseases nationwide. Founded in 1946 as the “Beiping Municipal Infectious Disease Hospital,” the institution has evolved over 77 years into a national medical center integrating medical care, teaching, research, and prevention. It specializes in infectious diseases, hepatology, and HIV/AIDS while providing comprehensive treatment for other legally designated infectious diseases. The hospital serves patients from all 31 provinces (autonomous regions and municipalities) across China and over 120 countries worldwide. It handles over 2 million outpatient visits annually and admits more than 30,000 critically ill patients each year. Its technical capabilities in treating emerging infectious diseases (such as COVID-19, SARS, and H1N1 influenza), end-stage liver disease, and HIV/AIDS are internationally recognized as leading. During major public health crises like the 2003 SARS outbreak and the 2020 COVID-19 pandemic, the hospital served as Beijing's designated treatment center, achieving the remarkable feat of “zero infections and zero deaths” in its containment efforts. It is widely recognized as the “national team for infectious disease prevention and control.”
I. Hospital Overview: The National Team Guarding the “Frontline of Life” in Infectious Disease Control
Located at No. 8 Jingshun East Street, Chaoyang District, Beijing, adjacent to Beijing Capital International Airport, the hospital spans approximately 350,000 square meters with over 2,000 open beds. It employs more than 3,200 staff members, including over 600 senior-level specialists and more than 180 doctoral/master's supervisors. The hospital features four core disciplinary clusters: Infectious Diseases, Hepatology, HIV/AIDS, and Critical Care Medicine, alongside specialized departments including Integrated Traditional and Western Medicine, Obstetrics and Gynecology, and Dermatology and Venereology. It hosts key national/provincial platforms such as the National Clinical Research Center for Infectious Diseases, Beijing Artificial Liver Treatment and Training Center, and the National Administration of Traditional Chinese Medicine Key Laboratory for Infectious Diseases. It serves as a doctoral/master's training base for Capital Medical University in Infectious Diseases, Hepatology, and Integrated Traditional and Western Medicine, annually cultivating hundreds of infectious disease specialists for the nation. and Master's programs in Infectious Diseases, Hepatology, and Integrated Traditional and Western Medicine at Capital Medical University, training hundreds of infectious disease specialists annually for the nation. Distinguished by its “dual-use” approach, the hospital provides routine infectious disease diagnosis and treatment during peacetime while rapidly converting into a treatment base for emerging and sudden infectious diseases during emergencies. It serves as a “core hub” within China's infectious disease prevention and control system.
II. Technical Advantages: Full-Chain Innovation from “Emergency Treatment” to “Comprehensive Management”
With the goal of “solving complex challenges and leading innovation,” the hospital has established a full-chain technical system encompassing “prevention-diagnosis and treatment-rehabilitation-prevention” in the fields of infectious diseases, liver diseases, and HIV/AIDS. It demonstrates particular strengths in treating emerging and sudden infectious diseases and managing chronic infectious diseases throughout their entire course:
• Emerging and Emerging Infectious Diseases: “Rapid Response + Precision Treatment”
The hospital operates a National Infectious Disease Emergency Testing Laboratory capable of rapid detection of over 200 pathogens, including SARS-CoV-2 and influenza viruses, within 2 hours. It pioneered personalized “one-patient-one-plan” treatment protocols, employing combined therapies of artificial liver support + ECMO + immunomodulation for critically ill patients (e.g., COVID-ARDS, sepsis), achieving an 85% 28-day survival rate—a globally leading outcome. During the 2020 COVID-19 pandemic, the hospital served as Beijing's Critical Care Center, successfully treating over 1,000 critically ill patients. Its experience was incorporated into national clinical guidelines.
• Liver Disease & Cirrhosis: Dual Goals of “Reversal + Cancer Prevention”
For chronic hepatitis (HBV, HCV), the hospital implements a comprehensive “antiviral + antifibrotic + immunomodulatory” approach, achieving a 38% clinical cure rate for HBV (exceeding the international average) and over 99% cure rate for HCV. In cirrhosis treatment, innovative techniques like “Transjugular Intrahepatic Portosystemic Shunt (TIPS)” and Endoscopic Precision Occlusion of Esophageal and Gastric Varices have reduced mortality from variceal bleeding in cirrhotic patients from 30% to below 4%. For hepatocellular carcinoma, the hospital performs ”Da Vinci Robot-Assisted Hepatectomy,“ ”ALPPS Two-Stage Hepatectomy,“ and ”Targeted + Immunotherapy Combination," achieving a 5-year survival rate of 75% for early-stage liver cancer (leading domestically).
• HIV/AIDS: “Comprehensive Management + Functional Restoration”
As the National HIV/AIDS Quality Control Center, the HIV/AIDS Department spearheaded the development of the Chinese HIV/AIDS Diagnosis and Treatment Guidelines. Antiviral treatment coverage for HIV-infected individuals exceeds 97%, with mortality rates dropping from 18% in 2003 to below 0.8% currently. For opportunistic infections in AIDS patients (e.g., Pneumocystis pneumonia, cryptococcal meningitis), the department employs “rapid pathogen diagnosis + novel antifungal drugs,” achieving a rescue success rate exceeding 92%. An innovative “psychological intervention + nutritional support” model helps patients rebuild social functioning, with HIV patients' quality of life scores improving by 40%.
• Integrative Medicine: “Distinctive Therapies + Synergistic Enhancement”
The Department of Integrative Medicine combines traditional Chinese herbal formulas (e.g., Turtle Shell Decoction Pills, Zhengqi Huayu Capsules) with modern medical approaches. This integration has demonstrated significant efficacy in reversing liver fibrosis, rebuilding HIV immunity, and supporting treatment for severe infections. Related achievements received the Second Prize of the National Science and Technology Progress Award.
III. Leading Specialties: A Core Discipline Matrix Covering Prevention, Diagnosis, Treatment, and Rehabilitation
The hospital boasts eight National Key Clinical Specialties (Infectious Diseases, Hepatology Center, HIV/AIDS, Critical Care Medicine, Integrated Traditional and Western Medicine, Radiology, Pathology, Obstetrics and Gynecology), including:
• Infectious Diseases Department: One of China's largest infectious disease centers, treating over 60,000 patients annually. It possesses extensive expertise in managing complex cases such as unexplained fever, central nervous system infections (e.g., tuberculous meningitis), and non-tuberculous mycobacterial diseases. It has ranked first in infectious diseases on Fudan University's “China Hospital Specialty Rankings” for 15 consecutive years.
• Liver Disease Center: Integrates diagnosis and treatment of hepatitis, cirrhosis, and hepatocellular carcinoma. Performs over 15,000 liver biopsy procedures annually, achieving 97% accuracy in non-invasive liver fibrosis assessment (FibroScan) and a 45% success rate in cirrhosis reversal therapy (world-leading).
• AIDS Department: One of the world's largest AIDS clinical research bases, achieving over 99% success rate in HIV post-exposure prophylaxis (PEP). It has spearheaded over 20 international multicenter clinical trials, advancing China's AIDS treatment to align with global standards.
• Critical Care Medicine (ICU): A National Key Clinical Specialty equipped with internationally advanced artificial liver support systems (DPMAS + plasma exchange) and ECMO (extracorporeal membrane oxygenation). Successfully treats numerous patients with severe hepatitis, sepsis, and septic shock, achieving an 80% 28-day survival rate for acute liver failure patients (leading domestically).
IV. Departmental Structure: Comprehensive Patient Care
Beyond core specialties, the hospital operates:
• Infectious Disease Center (diagnosis/treatment of brucellosis, dengue fever, malaria, etc.)
• Gastroenterology (management of cirrhosis complications)
• Obstetrics & Gynecology (hepatitis B/HIV mother-to-child transmission prevention with >99% success rate)
• Dermatology & Venereology (standardized treatment for genital warts, syphilis), Emergency Department (24/7 care for acute fever, hemorrhagic fever, and other critical cases), Laboratory Center (viral load, genetic resistance testing), Radiology Department (hepatic arteriography, dynamic contrast-enhanced liver MRI), and over 30 other clinical departments. Supported by the Pathology Department (liver histological grading, molecular tumor pathology) and the Ultrasound Department (hepatocellular carcinoma ultrasound contrast imaging). This forms an integrated service network encompassing diagnosis, treatment, and rehabilitation.
V. Medical Equipment: World-Class Devices Empowering Precision Diagnosis and Treatment
The hospital is equipped with globally leading medical devices to support the diagnosis and treatment of complex and critical conditions:
• Viral and Genetic Testing Equipment: • Roche Cobas 6800 fully automated nucleic acid analyzer (gold standard for HBV/HCV viral load detection) • Illumina NextSeq 550 sequencer (HIV drug resistance gene and hepatocellular carcinoma driver gene detection)
• Hepatology Treatment Systems: Fresenius (Germany) Artificial Liver Support System (DPMAS + plasma exchange), Olympus (Japan) Electronic Gastroscope (precision treatment for esophageal and gastric varices), Echosens (France) FibroScan 502 (non-invasive liver fibrosis diagnosis).
• Oncology and Surgical Equipment: Siemens PET-CT (Germany) (early liver cancer screening), Philips Ingenia 3.0T MRI (Netherlands) (precision imaging of liver tumors), Da Vinci Xi Surgical Robot (minimally invasive procedures including liver resection and kidney transplantation).
• Critical Care Equipment: Medtronic (USA) ECMO (extracorporeal membrane oxygenation), Dräger (Germany) Evita V300 ventilator (ARDS treatment), Terumo (Japan) continuous renal replacement therapy (CRRT) system.
VI. International Patient Services: Global Healthcare with “Chinese Warmth”
As a “WHO Collaborating Center” and “National Health Commission Designated Unit for International Medical Services,” the hospital serves as a key referral destination for infectious disease, liver disease, and HIV/AIDS patients from Southeast Asia, Africa, Europe, and the Americas. It provides comprehensive convenience services for international patients:
• Multilingual Support: The International Medical Department employs professional translators fluent in over 10 languages, including English, French, Spanish, Swahili, and Arabic. Medical staff maintain basic foreign language communication skills. Critical examination reports (e.g., CT scans, pathology) are provided in bilingual Chinese-English versions.
• One-Stop Service: Assistance with registration, examination scheduling, medical record translation, visa extensions, and other procedures. Priority access to consultations is offered (emergency patients seen within 30 minutes).
• International Insurance Coverage: Partnering with global insurers, including MSH (Wanxinhe), Cigna, and Aetna, to support direct billing for overseas medical insurance, enabling international credit card payments and cross-border transactions (Alipay/WeChat Pay).
• Cultural Adaptation Services: Provide diverse dietary options, including halal meals, vegetarian options, and low-fat meals in patient rooms; respect religious customs (e.g., Islamic prayer times, Christian holiday greetings); equipped with religious activity rooms and dedicated psychological counseling specialists.
• Telemedicine: Collaborations established with Johns Hopkins Hospital (USA), Royal Free Hospital (UK), and University of the Witwatersrand Hospital (South Africa). Complex cases can undergo joint video consultations with international expert panels.
VII. International Patient Testimonials: “Technical Excellence, Humanistic Care”
• Sipho (42, South Africa, Hepatitis B-related Cirrhosis): "After three years of treatment in South Africa with recurrent ascites, doctors at Ditan Hospital prescribed an ‘antiviral + artificial liver + traditional Chinese medicine’ regimen. Within one month, my ascites resolved, and liver function markers significantly improved. Nurses taught me to track my diet via a mobile app and gifted me the English edition of the Hepatitis B Self-Management Handbook upon discharge."
• Emma (31, AIDS with Kaposi's sarcoma, USA): "I never expected to live past 30. But at Ditan's Oncology Department, doctors controlled my tumors with ‘immunotherapy + targeted drugs,’ and my skin lesions significantly improved. My CD4 count has risen from 150 to 600, and doctors say I can resume normal work and life."
• Myanmar patient Ko Zaw (29, severe dengue fever): "After five days of high fever in Myanmar, I was admitted to Ditan Hospital. Doctors treated me with ‘antiviral therapy + fluid replacement + immune modulation,’ and my temperature dropped within three days. The ward nurses chatted with me daily and helped contact my family, making me feel never alone."
VIII. Contact Information & Transportation Guide
• Hospital Address: No. 8 Jingshunde Street, Chaoyang District, Beijing (Main Campus of Beijing Ditan Hospital Affiliated to Capital Medical University).
• Consultation Hotline: 010-84322000 (Main Switchboard), 010-84322120 (International Patient Service Line).
• WeChat Official Account: Search “Beijing Ditan Hospital Service Account” for online appointments, report inquiries, and access infection/liver disease prevention resources.
• Transportation Routes:
• Subway: Exit C at Wangjing East Station (Line 15), 10-minute walk;
• Bus: Take routes 401, 403, 404, etc., to Jingshun East Street Station;
• Driving: Underground parking available (10 RMB/hour). Nearby parking at Wangjing CapitaMall (8-minute walk).
Beijing Ditan Hospital upholds the mission of “Life First, Health Protection.” With its deep expertise in treating emerging and infectious diseases, comprehensive management of chronic infectious diseases, continuous technological innovation, and compassionate care for domestic and international patients, it remains a trusted “Guardian of Infectious Disease Health.” Whether providing standardized treatment for common hepatitis or tackling complex critical cases through multidisciplinary collaboration, the hospital delivers high-quality, compassionate medical services to patients worldwide, embodying the essence of “Chinese wisdom.”
Document dated 2025-09-15 14:49 Modify